18 results
Alternatives to opioids for pain management in the emergency department decreases opioid usage and maintains patient
Alternatives to opioids ... for pain management ... #Pharmacology # ... PainSyndromes #Indications ... #Pathways #Table
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
(PAMI) - Neuropathic ... Pain Medications ... #Pain #Pharmacology ... #Neuropathic #Medications ... Doses #Dosing #Table
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... (PAMI) - Non-Opioid ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... Doses #Dosing #Table
ED Opioid Stewardship Algorithm

Opioid Naive vs Opioid Tolerant

1. Patient Specific, Pain Syndrome-Targeted Approach
2. Combinations of Non-Pharmacologic
Combinations of Non-Pharmacologic ... Medication Assisted ... Treatment (MAT) ... Stewardship #Algorithm #Management ... #Pain #ED
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... 2020 #Drugs #Medications ... #Pharmacology # ... Table #Management
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... Pain Management ... capsaicin cream • Neuropathic ... #Table #Ladder ... #medications #pharmacology
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Inpatient Management ... Buprenorphine - Comparison Table ... interested in medication ... Buprenorphine #Comparison #Pain ... #Management #Opioid
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... #Prevention #Treatment ... infections #HIVAIDS #management ... pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... chew, or crush tablet ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
for Preventing ... with ARV (see Table ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology